Fed. Circ. Says Judge Wrongly Axed Teva's $177M Eli Lilly Win

By Ryan Davis · April 16, 2026, 6:58 PM EDT

The Federal Circuit ruled Thursday that a Massachusetts federal judge was wrong to overturn a $177 million jury verdict that Teva won against Eli Lilly & Co. on headache drug patents,...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Opinion

Case Information

Case Title

Teva Pharmaceuticals International GmbH v. Eli Lilly and Company

Case Number

Court

Appellate - Federal Circuit

Nature of Suit

830 Patent Infringement (Fed. Qst.)

Date Filed

October 30, 2023

Recent Articles By Ryan

April 13, 2026
Hikma Tells Justices Cox Ruling Boosts 'Skinny Label' Case
March 30, 2026
Don't Set Special IP Rules For 'Skinny Labels,' Justices Told
March 23, 2026
Amarin Tells Justices Hikma Drug Patent Appeal Threatens IP
March 19, 2026
Apple Watch Redesign Gets Early OK As Patent Loss Upheld
March 10, 2026
Justices Advised To Keep Law Clear In 'Skinny Label' Case
February 26, 2026
Justices Told 'Skinny Label' Case Puts Generic Drugs At Risk
January 20, 2026
Justices To Clarify What's Fair Game With 'Skinny Labels'
January 16, 2026
Supreme Court Takes On Hikma's 'Skinny Label' Patent Case
December 23, 2025
Justices Urged To Spurn SG's Call To Tackle 'Skinny Labels'
December 19, 2025
Squires Issues 21 More Patent Review Denials